Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk | Eli Lilly and Company

The Investor Relations website contains information about Eli Lilly and Company’s business for stockholders, potential investors, and financial analysts.

Read the full article here

Related Articles